ES2072749T5 - Diagnostico de la hipertermia maligna porcina. - Google Patents

Diagnostico de la hipertermia maligna porcina.

Info

Publication number
ES2072749T5
ES2072749T5 ES92901384T ES92901384T ES2072749T5 ES 2072749 T5 ES2072749 T5 ES 2072749T5 ES 92901384 T ES92901384 T ES 92901384T ES 92901384 T ES92901384 T ES 92901384T ES 2072749 T5 ES2072749 T5 ES 2072749T5
Authority
ES
Spain
Prior art keywords
pct
maligine
hyperthermia
swine
diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92901384T
Other languages
English (en)
Other versions
ES2072749T3 (es
Inventor
David H Maclennan
Peter J O'brien
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Toronto Innovations Foundation
University of Guelph
Original Assignee
University of Toronto Innovations Foundation
University of Guelph
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27265419&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2072749(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB909027869A external-priority patent/GB9027869D0/en
Priority claimed from GB919110865A external-priority patent/GB9110865D0/en
Priority claimed from GB919119250A external-priority patent/GB9119250D0/en
Application filed by University of Toronto Innovations Foundation, University of Guelph filed Critical University of Toronto Innovations Foundation
Publication of ES2072749T3 publication Critical patent/ES2072749T3/es
Application granted granted Critical
Publication of ES2072749T5 publication Critical patent/ES2072749T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/40—Disorders due to exposure to physical agents, e.g. heat disorders, motion sickness, radiation injuries, altitude sickness, decompression illness

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Radiation-Therapy Devices (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)
  • Finger-Pressure Massage (AREA)
  • Electrotherapy Devices (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

UNA MOLECULA DE DNA PURIFICADA COMPRENDE UNA SECUENCIA DE DNA DE APROXIMADAMENTE 15,1 KB DE CODIFICACION PARA PROTEINA RYR1 NORMAL O MUTANTE QUE TIENE UN PESO MOLECULAR DE APROXIMADAMENTE 564.740 DALTONS. LA MOLECULA DE DNA TIENE UN MAPA DE RESTRICCION ENDONUCLEASA DE LA FIGURA 1 Y UNA SECUENCIA DE LA FIGURA 2.
ES92901384T 1990-12-21 1991-12-20 Diagnostico de la hipertermia maligna porcina. Expired - Lifetime ES2072749T5 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB909027869A GB9027869D0 (en) 1990-12-21 1990-12-21 Diagnosis for porcine malignant hyperthermia
GB919110865A GB9110865D0 (en) 1991-05-20 1991-05-20 Diagnosis for porcine malignant hyperthermia
GB919119250A GB9119250D0 (en) 1991-09-09 1991-09-09 Diagnosis of porcine malignant hyperthermia

Publications (2)

Publication Number Publication Date
ES2072749T3 ES2072749T3 (es) 1995-07-16
ES2072749T5 true ES2072749T5 (es) 2003-11-16

Family

ID=27265419

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92901384T Expired - Lifetime ES2072749T5 (es) 1990-12-21 1991-12-20 Diagnostico de la hipertermia maligna porcina.

Country Status (12)

Country Link
US (1) US5358649A (es)
EP (1) EP0563144B2 (es)
AT (1) ATE120488T1 (es)
AU (1) AU665178B2 (es)
CA (2) CA2064091C (es)
DE (2) DE563144T1 (es)
DK (1) DK0563144T4 (es)
ES (1) ES2072749T5 (es)
IE (1) IE67816B1 (es)
NZ (1) NZ241112A (es)
WO (1) WO1992011387A1 (es)
ZA (1) ZA9110087B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668006A (en) * 1992-07-17 1997-09-16 American Cyanamid Company Somatostatin receptors
GB9503808D0 (en) * 1995-02-24 1995-04-12 Univ Nottingham Detection assay
GB2333154B (en) * 1996-10-07 2001-05-09 Meat And Livestock Commission Assay for duroc muscle fibre tyre
WO1998015837A1 (en) * 1996-10-07 1998-04-16 Meat And Livestock Commission Assay for duroc muscle fibre type
ES2203958T3 (es) * 1997-05-20 2004-04-16 Biotechnology Research And Development Corporation Metodos y composiciones para la identificacion de cerdos geneticamente resistentes a enfermedades relacionadas con e. coli f18.
US6355859B1 (en) 1997-05-20 2002-03-12 Biotechnology Research And Development Corporation Interactions between genotype and diet in swine that prevent E. coli associated intestinal disease
US6306591B1 (en) 1997-06-18 2001-10-23 Utah State University Screening for the molecular defect causing spider lamb syndrome in sheep
EP1026244A1 (en) * 1999-02-03 2000-08-09 Europäisches Laboratorium Für Molekularbiologie (Embl) Proteins Capable of Triggering G2/M transition and of Interacting with CDC2- and Cyclin B
NO314277B1 (no) * 1999-06-08 2003-02-24 Unifob Stiftelsen Universitets Deteksjon av ryanodin-reseptor-antistoff
WO2006013072A2 (en) 2004-08-02 2006-02-09 Basf Plant Science Gmbh Method for isolation of transcription termination sequences

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341094C (en) * 1989-09-25 2000-09-05 Ronald G. Worton Diagnosis for malignant hyperthermia

Also Published As

Publication number Publication date
ES2072749T3 (es) 1995-07-16
CA2079702A1 (en) 1992-06-22
ATE120488T1 (de) 1995-04-15
EP0563144B1 (en) 1995-03-29
EP0563144A1 (en) 1993-10-06
NZ241112A (en) 1993-09-27
US5358649A (en) 1994-10-25
DE69108568T2 (de) 1995-12-14
AU9103891A (en) 1992-07-22
DE563144T1 (de) 1994-02-03
DE69108568D1 (de) 1995-05-04
IE914495A1 (en) 1992-07-01
DK0563144T4 (da) 2003-03-31
WO1992011387A1 (en) 1992-07-09
CA2064091A1 (en) 1992-06-22
DK0563144T3 (da) 1995-08-28
AU665178B2 (en) 1995-12-21
IE67816B1 (en) 1996-05-01
DE69108568T3 (de) 2004-03-04
CA2064091C (en) 1993-03-16
EP0563144B2 (en) 2003-02-19
ZA9110087B (en) 1992-10-28

Similar Documents

Publication Publication Date Title
ITTO950367A0 (it) Proteine di prrsv ricombinanti, corredi diagnostici e vaccini contenenti tali proteine di prrsv ricombinanti.
HUP0104468A2 (hu) Elkülönített dimer fibroblaszt aktivációs alfa-protein és alkalmazása
DE3768492D1 (de) Luftfeder, balg und verfahren.
ATE328896T1 (de) Faktor viii vom schwein und hybriden
DE3750829D1 (de) System für medizinische Information.
ATE184052T1 (de) Gdf-1 und uog1 proteine
ES2072749T5 (es) Diagnostico de la hipertermia maligna porcina.
GR3022052T3 (en) Dna sequences which code for virulence characteristics of --(streptococcus suis) and parts thereof, polypeptides and antibodies derived therefrom and the use thereof for the diagnosis of and protection against infection by --(s. suis) in mammals, including man
ES2146214T3 (es) Vacunas para actinobacillus pleuropneumoniae.
DE69232483D1 (de) Mycobacteriumprotein und dessen verwendung
ATE218616T1 (de) Humanes zirkulierendes cytokin cc-1
DK0840792T3 (da) (S)-hydroxynitrillyase fra Hevea brasiliensis
ATE41773T1 (de) 4,5-dihydro-4-oxo-2((2-transphenylcyclopropyl)amino>-3-furancarbonsaeuren und derivate davon.
DE69728897D1 (de) Saeugetierchemokine
DK1431391T3 (da) RANTES-mutanter og terapeutiske anvendelser heraf
DE69014383D1 (de) Siloxankautschukzusammensetzung.
IT8621450A0 (it) Composizione sterilizzante adattivita' antibatterica e antimicetica a base di glutaraldede, in veicolo acquoso.
DK0773999T3 (da) OR-1, en orphan-receptor tilhørende kernereceptorfamilien
DK0919621T3 (da) Human TAK1 og DNA der koder derfor
PE20399A1 (es) Muteina ob
TR200003608T2 (tr) Moraxella Catarrhalis'e ait BASB027 proteinleri ve genleri.
ATE186731T1 (de) Anomere fluorribosylamine
DE69022560D1 (de) N,N'-hydrocarbylen-bis-(N-hals)-substituierte Amidhydrazide.
IT8221070A0 (it) Procedimento di alogenazione di n-(o,o'-dialchilfenil) alaninati e omologhi.
NZ330913A (en) Antigens for preventing and reducing parasite infection and disease

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 563144

Country of ref document: ES